Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.35 |
| ▸ | HMBS | P08397 | 1/20 | 0.32 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6920477 | 0.82 | — | — | |
| SCHEMBL13508327 | 0.80 | — | — | |
| SCHEMBL12562951 | 0.80 | — | — | |
| SCHEMBL10092848 | 0.76 | GPR84 (0.30) | — | |
| SCHEMBL12180269 | 0.74 | DAO (0.39) | DAOHCAR2 | |
| SCHEMBL12740601 | 0.74 | GABRA1 (0.35) | — | |
| SCHEMBL12180533 | 0.74 | DAO (0.39) | DAO | |
| SCHEMBL12740587 | 0.72 | KDM4E (0.44) | DAOHCAR3HCAR2 | |
| SCHEMBL25093855 | 0.71 | GRIN2D (0.39) | DAO | |
| SCHEMBL179270 | 0.70 | MMP1 (0.44) | DAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118239981-A | Phosphonite ligand, catalyst and application thereof in hydroformylation reaction | 万华化学集团股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| US-8362278-B2 | Methods for the conversion of a substituted furan to a substituted pyrrole | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-01-29 | — | — | US | claimed |
| US-20120083609-A1 | METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-04-05 | — | — | US | claimed |
| EP-4737461-A1 | NOVEL COMPOUND, PRECURSOR COMPOSITION COMPRISING SAME, AND METHOD FOR MANUFACTURING THIN FILM USING SAME | Hansol Chemical Co., Ltd (KR) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025005677-A1 | NOVEL COMPOUND, PRECURSOR COMPOSITION COMPRISING SAME, AND METHOD FOR MANUFACTURING THIN FILM USING SAME | 주식회사 한솔케미칼 | 2025-01-02 | — | — | WO | disclosed |
| CN-118239981-A | Phosphonite ligand, catalyst and application thereof in hydroformylation reaction | 万华化学集团股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| EP-4359382-A1 | TWO-STEP SYNTHESIS OF PYRROLE COMPOUNDS FROM FURAN COMPOUNDS | Chevron Phillips Chemical Company LP (US) | 2024-05-01 | — | — | EP | disclosed |
| CN-117881658-A | Two-step synthesis of pyrrole compounds from furan compounds | 切弗朗菲利浦化学公司 | 2024-04-12 | — | — | CN | disclosed |
| US-20230382889-A1 | COMPOUNDS FOR INHIBITING KIF18A | VOLASTRA THERAPEUTICS, INC. (US) | 2023-11-30 | — | — | US | disclosed |
| US-20230382889-A1 | COMPOUNDS FOR INHIBITING KIF18A | VOLASTRA THERAPEUTICS, INC. (US) | 2023-11-30 | — | — | US | disclosed |
| US-20230372496-A1 | TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS | C4 THERAPEUTICS, INC. (US) | 2023-11-23 | — | — | US | disclosed |
| WO-2009120717-A2 | PYRIDO [3, 4-B] INDOLES AND METHODS OF USE | MEDIVATION TECHNOLOGIES, INC. (US) | 2009-10-01 | — | — | WO | disclosed |
| US-20090239854-A1 | Tetracyclic compounds | MEDIVATION TECHNOLOGIES, INC. | 2009-09-24 | — | — | US | disclosed |
| WO-2009055828-A1 | NEW TETRACYCLIC COMPOUNDS | MEDIVATION TECHNOLOGIES, INC. (US) | 2009-04-30 | — | — | WO | disclosed |
| US-20080097078-A1 | Antibacterial activity against vancomycin-resistant bacteria | SHIONOGI & CO., LTD. (JP) | 2008-04-24 | — | — | US | disclosed |
| US-7291693-B2 | Bioerodible conducting materials | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-11-06 | — | — | US | disclosed |
| US-20070238694-A1 | Purine compounds and methods of use thereof | INOTEK PHARMACEUTICALS CORPORATION (US) | 2007-10-11 | — | — | US | disclosed |
| US-7273940-B2 | Catalysts for the polymerization of unsaturated compounds | BASELL POLYOLEFINE GMBH (DE) | 2007-09-25 | — | — | US | disclosed |
| US-20050085527-A1 | Catalysts for the polymerization of unsaturated compounds | EQUISTAR CHEMICALS, LP | 2005-04-21 | — | — | US | disclosed |
| US-6818715-B1 | LIGAND SYSTEM FOR NOVEL COMPLEXES CONTAINING LATE TRANSITION METALS WHICH CAN BE USED FOR POLYMERIZATION OF UNSATURATED COMPOUNDS AND GIVE BRANCHED POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382889-A1 | COMPOUNDS FOR INHIBITING KIF18A | KIF18A, KIF18B, KIF2C | DAO 4673/4885HMBS 4515/4885HCAR3 3889/4885 |
| US-20120083609-A1 | METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE | PAH, CPS1, ASNS | DAO 23/4885HMBS 50/4885HCAR3 3063/4885 |
| US-20230372496-A1 | TRICYCLIC HETEROBIFUNCTIONAL COMPOUNDS FOR DEGRADATION OF TARGETED PROTEINS | CRBN, CDR2, MDM2 | DAO 1199/4885HMBS 1052/4885HCAR3 3811/4885 |
| US-20070238694-A1 | Purine compounds and methods of use thereof | PNP, ADORA2A, P2RY1 | DAO 357/4885HMBS 737/4885HCAR3 1116/4885 |
| US-20050085527-A1 | Catalysts for the polymerization of unsaturated compounds | NR0B2, NR4A1, CBR1 | DAO 1663/4885HMBS 3354/4885HCAR3 480/4885 |
| US-20080097078-A1 | Antibacterial activity against vancomycin-resistant bacteria | CSGALNACT1, MON2, NR2C2 | DAO 196/4885HMBS 4708/4885HCAR3 126/4885 |
| US-20090239854-A1 | Tetracyclic compounds | HTR2C, HTR3D, HTR5A | DAO 953/4885HMBS 764/4885HCAR3 62/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.